From: Can pelvic diameter measurement have an effect on surgical outcomes in radical cystectomy?
Complication | OR (%95 CI) | p |
LC | 0.542 (0.284–1.034) | 0.063 |
ISD index | 0.577 (0.037–8.996) | 0.695 |
BFW index | 4.868 (0.335–70.752) | 0.246 |
BMI | 1.176 (0.986–1.403) | 0.072 |
Charlson comorbidity group (score ≥ 5) | 4.197 (1.118–15.756) | 0.034 |
ASA score | 1.351 (0.443–4.122) | 0.597 |
Clinical LN status | 2.927 (0.764–11.217) | 0.117 |
Pathological stage | 1.057 (0.656–1.702) | 0.821 |
Major complication | OR (%95 CI) | p |
AD | 2.664 (0.730–9.717) | 0.138 |
ISD index | 0.444 (0.033–5.971) | 0.540 |
Charlson comorbidity group (score ≥ 5) | 3.357 (1.009–11.169) | 0.048 |
Clinical LN status | 0.638 (0.166–2.447) | 0.512 |
Pathological stage | 1.634 (0.943–2.833) | 0.080 |
LC | 1.754 (0.889–3.463) | 0.105 |
BMI | 1.288 (1.032–1.608) | 0.025 |
ASA score | 2.664 (0.730–9.717) | 0.138 |
Mortality within 90 day | OR (%95 CI) | p |
AD | 0.673 (0.014–32.028) | 0.841 |
ISD index | 0.066 (0.001–4.264) | 0.201 |
LC | 1.781 (0.576–5.501) | 0.316 |
UC | 1.245 (0.411–3.771) | 0.698 |
Charlson comorbidity group (score ≥ 5) | 11.492 (1.679–78.645) | 0.013 |
BMI | 1.252 (0.874–1.794) | 0.220 |
Perioperative complication | 4.492 (0.408–49.498) | 0.220 |
Pathological stage | 1.555 (0.721–3.351) | 0.260 |
Clinical LN status | 1.220 (0.146–10.229) | 0.854 |
Positive surgical margin | OR (%95 CI) | p |
ISD index | 0.022 (0.001–0.524) | 0.018 |
Pathological stage | 12.824 (2.619–62.806) | 0.002 |
Charlson comorbidity group (score ≥ 5) | 7.563 (1.008–56.722) | 0.049 |